| SC 13G | 2020-06-12 | Valiant Capital Management, L.P. | HUMANIGEN, INC | 27,011,494 | 12.9% | EDGAR |
| SC 13G | 2020-06-12 | Venrock Healthcare Capital Partners II, L.P. | HUMANIGEN, INC | 17,241,379 | 8.3% | EDGAR |
| SC 13D/A | 2020-04-07 | Cheval Holdings, Ltd. | HUMANIGEN, INC | 5,996,710 | 4.9% | EDGAR |
| SC 13G/A | 2019-02-13 | Nantahala Capital Management, LLC | HUMANIGEN, INC | 1,450,000 | 1.3% | EDGAR |
| SC 13D/A | 2018-03-05 | NOMIS BAY LTD. | HUMANIGEN, INC | 33,573,530 | 31.4% | EDGAR |
| SC 13D/A | 2018-03-01 | BLACK HORSE CAPITAL LP | HUMANIGEN, INC | 5,996,710 | 5.6% | EDGAR |
| SC 13G/A | 2018-02-14 | Nantahala Capital Management, LLC | HUMANIGEN, INC | 1,450,000 | 9.7% | EDGAR |
| SC 13D/A | 2018-02-01 | NOMIS BAY LTD. | HUMANIGEN, INC | 3,680,106 | 24.6% | EDGAR |
| SC 13D/A | 2018-01-26 | BLACK HORSE CAPITAL LP | HUMANIGEN, INC | 872,977 | 5.8% | EDGAR |
| SC 13G | 2017-02-14 | Nantahala Capital Management, LLC | KALOBIOS PHARMACEUTICALS INC | 1,450,000 | 9.7% | EDGAR |
| SC 13D/A | 2016-08-29 | Shkreli Martin | KALOBIOS PHARMACEUTICALS INC | 0 | 0.0% | EDGAR |
| SC 13G | 2016-08-16 | Dhar Kapil | KALOBIOS PHARMACEUTICALS INC | 949,752 | 6.4% | EDGAR |
| SC 13D | 2016-07-13 | NOMIS BAY LTD. | KALOBIOS PHARMACEUTICALS INC | 3,719,006 | 25.0% | EDGAR |
| SC 13D | 2016-07-11 | BLACK HORSE CAPITAL LP | KALOBIOS PHARMACEUTICALS INC | 872,977 | 5.9% | EDGAR |
| SC 13D/A | 2016-07-07 | Moradi David | KALOBIOS PHARMACEUTICALS INC | 671,996 | 4.6% | EDGAR |
| SC 13G/A | 2016-02-16 | Flynn James E | KALOBIOS PHARMACEUTICALS INC | 0 | 0.0% | EDGAR |
| SC 13G/A | 2016-02-04 | First Eagle Investment Management, LLC | KALOBIOS PHARMACEUTICALS INC | 0 | 0.0% | EDGAR |
| SC 13D | 2015-12-18 | Moradi David | KALOBIOS PHARMACEUTICALS INC | 578,210 | 14.0% | EDGAR |
| SC 13G/A | 2015-12-18 | PRIMECAP MANAGEMENT CO/CA/ | KALOBIOS PHARMACEUTICALS INC | 0 | 0.0% | EDGAR |
| SC 13D | 2015-11-25 | Shkreli Martin | KALOBIOS PHARMACEUTICALS INC | 2,890,000 | 70.1% | EDGAR |